These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2573209)

  • 1. Use of continuous infusion of histamine2-receptor antagonists in critically ill patients.
    Siepler JK; Trudeau W; Petty DE
    DICP; 1989 Oct; 23(10 Suppl):S40-3. PubMed ID: 2573209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dosage alternative for H2-receptor antagonists--constant infusion.
    Siepler JK
    Clin Ther; 1986; 8 Suppl A():24-33. PubMed ID: 2878728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Parenteral histamine2-receptor antagonists.
    Skoutakis VA
    DICP; 1989 Oct; 23(10 Suppl):S17-22. PubMed ID: 2573205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists.
    Moore JG
    DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of stress ulcers: antacid titration vs. histamine2-receptor blockade.
    Gonzalez ER; Morkunas AR
    Drug Intell Clin Pharm; 1985 Nov; 19(11):807-11. PubMed ID: 2866078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations for selection of parenteral histamine (H2)-receptor antagonists.
    Wolfe MM
    Am J Med; 1987 Dec; 83(6A):82-8. PubMed ID: 2892411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical review of continuous infusion H2 receptor therapy.
    Rovers JP; Souney PF
    Crit Care Med; 1989 Aug; 17(8):814-21. PubMed ID: 2568898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost considerations of intravenously administered histamine2-receptor antagonists.
    Nolly RJ; Skoutakis VA
    DICP; 1989 Oct; 23(10 Suppl):S23-8. PubMed ID: 2573206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
    Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
    Bachmann K; Sullivan TJ; Jauregui L
    J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of parenteral histamine (H2)-antagonists in acid suppression for the prevention of stress ulceration.
    Critchlow JF
    Am J Med; 1987 Dec; 83(6A):23-8. PubMed ID: 2892406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress ulceration in the intensive care unit: use of H2-receptor antagonists.
    Moore JG
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():111-9. PubMed ID: 1679669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
    Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
    Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famotidine in the therapy of gastric hypersecretory states.
    Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
    Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ; Fennerty B; Fagan TC
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
    Weingart J; Kunert H; Ottenjann R
    Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists.
    Katsu K; Yabe S
    Clin Ther; 1995; 17(3):433-10. PubMed ID: 7585847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and acid-suppressant properties of histamine2-receptor antagonists for the prevention of stress-related mucosal damage in critical care patients.
    Schentag JJ; Carter CA; Welage LS
    DICP; 1989 Oct; 23(10 Suppl):S36-9. PubMed ID: 2573208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.
    Kett K; Aadland E; Berstad A
    Scand J Gastroenterol; 1980; 15(2):249-51. PubMed ID: 6104355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.